Phoenix AZ 肥胖症临床试验
19项针对 肥胖症的研究正在 Phoenix及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
招募中4 期
- Medical Dermatology Specialists, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
招募中3 期
- RIO Clinical Trials - Phoenix, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
招募中3 期
- Elite Clinical Studies, LLC, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
招募中2 期
- Helios Clinical Research - Phoenix, Phoenix
Early Tracking of Childhood Health Determinants (ETCHED) Study
招募中观察性研究欢迎健康志愿者
- NIDDK, Phoenix, Phoenix
Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
招募中1 期
- Arizona Research Center, Phoenix
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- Medical Advancement Centers of Arizona, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
招募中观察性研究
- Exponent Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期欢迎健康志愿者
- ACCOMPLISH-2 Research Site, Phoenix
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
招募中欢迎健康志愿者
- NIDDK, Phoenix, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Phoenix
The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
招募中欢迎健康志愿者
- NIDDK, Phoenix, Phoenix
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- Honor Health, Phoenix
- Arizona Research Center, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Phoenix
Fibrosis Lessens After Metabolic Surgery
招募中4 期欢迎健康志愿者
- Banner Health Center, Phoenix
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
招募中3 期
- Arizona Research Center, Inc., Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
招募中3 期
- The University of Arizona College of Medicine- Phoenix, Phoenix
其他城市的 肥胖症试验
- Houston, TX44 项研究
- Chicago, IL40 项研究
- New York City, NY39 项研究
- San Antonio, TX39 项研究
- Washington, DC34 项研究
- Dallas, TX33 项研究
- Orlando, FL33 项研究
- Miami, FL28 项研究
- Boston, MA26 项研究
- Atlanta, GA26 项研究
- Los Angeles, CA25 项研究
- St. Louis, MO25 项研究
Phoenix的其他研究
- 乳腺癌25 项研究
- 结直肠癌24 项研究
- 非小细胞肺癌21 项研究
- 转移性癌症19 项研究
- 胰腺癌18 项研究
- 癌症（所有类型）17 项研究
- 心血管疾病16 项研究
- 前列腺癌16 项研究
- 多发性骨髓瘤16 项研究
- 心力衰竭16 项研究
- 阿尔茨海默病15 项研究
- 急性髓系白血病13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。